Details of all studies including the allocated Drummond score
Author/date | Type of study | Test | Outcome | Case of PID prevented | Sensitivity analysis | Score on Drummond criteria (max 20) | |
---|---|---|---|---|---|---|---|
*Chlamydia trachomatis | |||||||
1 | Howell et al24 (1999) | Model using real data from records and previous cohort studies Military oriented | LCR urine | Age based testing or universal treatment in high prevalence groups | 233 cases of PID prevented saving of $800/PID | Yes, varied prevalence, cost, uptake and sensitivity | 16 |
High prevalence (9.2%) | |||||||
2 | Howell et al23 (1998) | Model 7 strategies to decide on test Extensive sequelae included | DNA amplification in urine or cervical swab in asymptomatic women less than 30 years. | 306 cases of PID prevented saving $3689/PID | Yes varied prevalence, cost, uptake and sensitivity | 17 | |
High prevalence (9.2%) | |||||||
3 | Howell et al22 (1998) | Model | Urine based NAA | Age based screening at less than 10.2% prevalence. Universal screening over 10.2% prevalence. Both in FPC. | 85 cases of PID prevented saving $3585/PID | Yes, varied prevalence, cost, uptake and sensitivity | 17 |
Cost effectiveness | |||||||
4 | Paavonen et al21 (1998) | Model | NAA on urine | Cost effective in low prevalence (3.9%) population using DNA based test assuming 90% return rate | 50% of sequelae prevented cost $45 per case of Ct* | Yes, extensive | 15 |
Cost effectiveness | |||||||
5 | Marazzo et al19 (1997) | Cross sectional study to provide data | EIA in several settings | Selective screening in GUM. Universal screening in FPC. | 44 674 cases of Ct* prevented a saving of $987 per case | Yes | 18 |
Both with EIA. | 47 025 cases prevented a saving of $667 | ||||||
6 | Genc and Mardh18 (1996) | Model | NAA | Cost effective in asymptomatic women in FPC with DNA based test at 6% prevalence, positives treated with azithromycin. | NA | None was performed | 12 |
Cost effectiveness Using local data. | |||||||
Dubious assumptions eg 100% cures | |||||||
7 | Sellors et al17 (1992) | Model | EIA | Selective screening using set criteria in low prevalence populations. Effective using EIA. | NA | Yes | 17 |
Cost effectiveness | |||||||
Data collected from longitudinal study and selective criteria developed | |||||||
8 | Buhaug et al15 (1990) | Model | Culture | Cost effective in GP in women <24 every 2 years | $1477 per case of PID prevented | No | 11 |
Cost minimisation | |||||||
Excluded | Cohen et al20 | Prospective | NAA | School based screening was cost effective | 3 | ||
Cost minimisation | |||||||
Excluded | Humphreys et al16 | Universal screening in FPC | 5 |